PCG
XLRN

Private Capital Group’s Acceleron Pharma XLRN Stock Holding History

Private Capital Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-45
Closed -$8K – 2233
2021
Q3 		$8K Hold
45
– – ﹤0.01% 1439
2021
Q2 		$6K Buy
+45
New +$5.68K ﹤0.01% 1533

Private Capital Group's XLRN Position: Q4 2021 in Review

Private Capital Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 45 shares — an estimated $8K sold.

Private Capital Group first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $8K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Private Capital Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Private Capital Group sold 45 Acceleron Pharma shares in Q4 2021, an estimated $8K.
  • Private Capital Group first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • Private Capital Group's Acceleron Pharma position peaked at $8K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Private Capital Group's 13F filing for Q4 2021, filed 24 Jan 2022.